Cambridge Trust CO Bristol Myers Squibb CO Transaction History
Cambridge Trust CO
- $2.6 Billion
- Q1 2024
A detailed history of Cambridge Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cambridge Trust CO holds 131,329 shares of BMY stock, worth $7.86 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
131,329
Previous 358,307
63.35%
Holding current value
$7.86 Million
Previous $18.4 Million
61.27%
% of portfolio
0.27%
Previous 0.78%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,760Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.49 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.74 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.69 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.61 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...